Mohamed I. A. Othman
Author
Alternate names Ahmed Al Othman, Ahmad H. S. Othman, Ahmed A. Othman, Abdelrahman I. Othman, Ahmad Othman +35 more
Institutions University Medical Center of the Johannes Gutenberg University Mainz, Johannes Gutenberg University Mainz
Past institutions King Saud University, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, University of Tübingen, British University in Egypt +5 more
ORCID: Yes
H-index: 39
I10-index: 191
Works count: 422
Citations count: 7,434
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial
2019 · Roy Fleischmann, Aileen L. Pangan, et al. · Arthritis & Rheumatology
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial
2018 · Gerd R Burmester, Joel M. Kremer, et al. · The Lancet
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
2019 · Josef S Smolen, Aileen L. Pangan, et al. · The Lancet